Literature DB >> 12856887

In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.

Timothy C Zhu1, Stephen M Hahn, Amy S Kapatkin, Andreea Dimofte, Carmen E Rodriguez, Teodor G Vulcan, Eli Glatstein, R Alex Hsi.   

Abstract

The optical properties (absorption [mu(a)], transport scattering [mu('s)] and effective attenuation [mu(eff)] coefficients) of normal canine prostate were measured in vivo using interstitial isotropic detectors. Measurements were made at 732 nm before, during and after motexafin lutetium (MLu)-mediated photodynamic therapy (PDT). They were derived by applying the diffusion theory to the in vivo peak fluence rates measured at several distances (3, 6, 9, 12 and 15 mm) from the central axis of a 2.5 cm cylindrical diffusing fiber (CDF). Mu(a) and mu('s) varied between 0.03-0.58 and 1.0-20 cm(-1), respectively. Mu(a) was proportional to the concentration of MLu.Mu(eff) varied between 0.33 and 4.9 cm(-1) (mean 1.3 +/- 1.1 cm(-1)), corresponding to an optical penetration depth (8 = 1/(mu(eff)) of 0.5-3 cm (mean 1.3 +/- 0.8 cm). The mean light fluence rate at 0.5 cm from the CDF was 126 +/- 48 mW/cm2 (N = 22) when the total power from the fiber was 375 mW (150 mW/cm). This study showed significant inter- and intraprostatic differences in the optical properties, suggesting that a real-time dosimetry measurement and feedback system for monitoring light fluences during treatment should be advocated for future PDT studies. However, no significant changes were observed before, during and after PDT within a single treatment site.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12856887     DOI: 10.1562/0031-8655(2003)077<0081:ivopon>2.0.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  25 in total

Review 1.  A review of in-vivo optical properties of human tissues and its impact on PDT.

Authors:  Julia L Sandell; Timothy C Zhu
Journal:  J Biophotonics       Date:  2011-11       Impact factor: 3.207

2.  Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Authors:  Zheng Huang; Qun Chen; Nadira Trncic; Susan M LaRue; Pierre-Hervé Brun; Brian C Wilson; Howard Shapiro; Fred W Hetzel
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

3.  A method for determination of the absorption and scattering properties interstitially in turbid media.

Authors:  Andreea Dimofte; Jarod C Finlay; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2005-05-05       Impact factor: 3.609

4.  Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate.

Authors:  Augusto Rendon; J Christopher Beck; Lothar Lilge
Journal:  Phys Med Biol       Date:  2008-02-05       Impact factor: 3.609

Review 5.  Photodynamic therapy for prostate cancer--a review of current status and future promise.

Authors:  Caroline M Moore; Doug Pendse; Mark Emberton
Journal:  Nat Clin Pract Urol       Date:  2009-01

6.  Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy.

Authors:  Jun Li; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2008-03-27       Impact factor: 3.609

7.  A fast heterogeneous algorithm for light fluence rate for prostate photodynamic therapy.

Authors:  Chang Chang; Ken K-H Wang; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-03-02

8.  Characterization of tissue optical properties for prostate PDT using interstitial diffuse optical tomography.

Authors:  Xing Liang; Ken Kang-Hsin Wang; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2012-01-21

9.  Pre-clinic study of uniformity of light blanket for intraoperative photodynamic therapy.

Authors:  Yida Hu; Ken Wang; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-01-23

10.  Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Jarod C Finlay; Timothy C Zhu; Andreea Dimofte; Diana Stripp; S Bruce Malkowicz; Theresa M Busch; Stephen M Hahn
Journal:  Photochem Photobiol       Date:  2006 Sep-Oct       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.